Table 1.
References | Study year† | Baseline | Outcomes | |||||
---|---|---|---|---|---|---|---|---|
No of patients | No of Ureters | OR time in min | Success rate# | Complications %* | ||||
Clavien grade 1 | Clavien grade 2 | Clavien grade 3 | ||||||
Peters (9) | 2004 | 24 | 27 | 165 | 88 | 11 | 5 | |
Chan et al. (12) | 2005–2008 | 3 | 4 | 210 | 66.7 | 33 | 0 | 0 |
Boysen et al. (7) | 2005–2014 | 260 | 363 | 177 | 87.9 | 5 | 1.9 | 2.7 |
Casale et al. (13) | 2006–2007 | 41 | 82 | 139.8 | 97.6 | 0 | 4.87 | 0 |
Smith et al. (17) | 2006–2009 | 25 | 33 | 185 | 95.6 | 16 | 0 | 4 |
Akhavan et al. (18) | 2006–2013 | 50 | 78 | – | 92.3 | 4 | 14 | 4 |
Chalmers et al. (19) | 2007–2010 | 16 | 22 | 152 | 90.9 | 0 | 0 | 0 |
Marchini et al. (11) (EV) | 2007–2010 | 20 | 27 | 233.5 | 100 | 10 | 10 | 0 |
Schomburg et al. (14) | 2008–2010 | 20 | 25 | 196 | 100 | 0 | 0 | 10 |
Gundeti et al. (20) | 2008–2015 | 58 | 83 | – | 82 | 1.7 | 0 | 0 |
Silay et al. (21) | 2008–2015 | 72 | 91 | – | 97.9 | 2.7 | 0 | 0 |
Katsturi et al. (22) | 2009–2011 | 150 | 300 | – | 99.3 | 0 | 0.7 | 0 |
Dangle et al. (23) | 2010–2013 | 29 | 40 | – | 80 | – | – | – |
Grimsby et al. (24) | 2010–2013 | 61 | 93 | – | 72 | 1.6 | 1.6 | 8.2 |
Srinivasan et al. (15) | 2012–2016 | 92 | – | 164 | 91.3 | 4.3 | 17 | 2.1 |
Hayashi et al. (25) | 2013 | 9 | 15 | 268.78 | 93.3 | 100 | 0 | 0 |
Arlen et al. (26) | 2013–2014 | 17 | 20 | 169.3 | 94.1 | 0 | 11.76 | 0 |
Herz et al. (27) | 2013–2015 | 54 | 72 | – | 85.2 | 5.5 | 9.8 | 11 |
Boysen et al. (8) | 2015–2017 | 143 | 199 | 194 | 93.8 | 4.9 | 0.7 | 5.6 |
Approximate period.
Clinical or radiological success rates.
Some reports did not report complications as per Clavien-Dindo grading directly; The reports were graded based on the description. Some authors included UTIs in the complications. There were no Grade-4 complications related to surgery reported in any of the studies. In many series, same patients have had complications of different grades, hence they cannot be summated.